In this webinar, we review the mechanisms driving NK cell activity in the context of immuno-oncology, and the types of NK-targeted immunotherapies currently under investigation. Then we introduce several experimental models used to evaluate these immunotherapies, including syngeneic models and xenograft models.

LINK TO THE WEBINAR SECTION YOU WANT:
"Our Syngeneic Models"
[ Ссылка ]

"Our Xenogeneic Models"
[ Ссылка ]

"Q&A Session"
[ Ссылка ]


To view Biocytogen's entire catalog of animal models and cell lines:
[ Ссылка ]

Broadcast on Aug 31, 2022

свернуть